Gynesonics announced that it has submitted its 510(k) Premarket Notification to the FDA for its Sonata System. The Sonata System is a uterus preserving, incision-free uterine fibroid treatment that was designed to treat fibroids transcervically with radiofrequency energy. “Submission of the 510(k) application is an important milestone for our company,” Chris Owens, president and CEO
Gynesonics submits 510(k) premarket notification for uterine fibroid treatment
December 21, 2017 By Leave a Comment
These 5 surgical startups want to build the OR of the future
November 14, 2017 By Leave a Comment
As with most medtech advances these days, a running theme among top surgical startups is value. Innovators presented their surgical platform products in various stages of development at this year’s AdvaMed MedTech Conference as part of the Medtech Innovator Program, offering a view of the future of ORs across the world. As mentioned, there are some running
7 breast cancer breakthroughs you need to know
October 5, 2017 By Leave a Comment
As we mark another Breast Cancer Awareness Month, it’s worth noting the recent strides that have been made when it comes to diagnosing and treating the disease. Breast cancer is the most common form of cancer in women in the U.S. Affecting one in eight women, breast cancer will be accountable for about 40,610 deaths
Study: Annual mammograms would prevent the most deaths
August 21, 2017 By Leave a Comment
(Reuters) – Yearly mammograms starting at age 40 would prevent the most deaths from breast cancer, U.S. researchers reported on Monday in a challenge to more conservative recommendations that take into account both the harms and the benefits of screening. The study, led by Dr. Elizabeth Arleo, a radiologist specializing in mammography at Weill Cornell Medicine
This new device could provide better cervical cancer screening
August 7, 2017 By Leave a Comment
Histologics has developed a small, Velcro hook-like device that is better able to consistently obtain samples of cells in the cervix during colposcopies to diagnose cervical cancer, according to researchers from the University of California at Riverside. Women who have an abnormal pap smear results usually have to have a colposcopy to closely examine the
Acessa Health closes bankruptcy buyout of Halt Medical, raises $30M
June 26, 2017 By Leave a Comment
Acessa Health said today that it closed the bankruptcy buyout of Halt Medical and promptly raised a Series A round worth $30 million. The Acessa device is designed to treat uterine fibroids using radiofrequency ablation. Its successor namesake emerged after a Delaware federal bankruptcy judge earlier this month approved the bankruptcy sale, which was designed to keep the
